(Q70041100)

English

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. II. Establishment of tumor-specific immunotherapy models utilizing MDP hapten-reactive helper T cell activity

scientific article published on 01 January 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. II. Establishment of tumor-specific immunotherapy models utilizing MDP hapten-reactive helper T cell activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

based on heuristic

inferred from title

author name string

H Sano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A Kosugi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

S Sano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

H Fujiwara

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

T Hamaoka

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

180-184

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00199145

0 references

Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of transplantation immunity by dansylated tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic approach to cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of specific suppression in effector T cell clones against tumor-associated transplantation antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppressive versus augmenting effect of the same pretreatment regimen in two murine tumor systems with distinct effector mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced immunogenicity of chemically-coated syngeneic tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2960447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00199145

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2960447%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70041100&oldid=1754487175"